Key Players of the Immunosuppressive Tumor Microenvironment and Emerging Therapeutic Strategies
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Key Players of the Immunosuppressive Tumor Microenvironment and Emerging Therapeutic Strategies
Authors
Keywords
-
Journal
Frontiers in Cell and Developmental Biology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-03-08
DOI
10.3389/fcell.2022.830208
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase 1 Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies
- (2021) Stephen M Ansell et al. CLINICAL CANCER RESEARCH
- Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2016–2020)
- (2021) Hyun Seung Ban et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy
- (2021) Bin Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor
- (2021) Yuying Liu et al. NATURE IMMUNOLOGY
- Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1
- (2021) Zi Yin et al. Journal for ImmunoTherapy of Cancer
- M2‐Like TAMs Function Reversal Contributes to Breast Cancer Eradication by Combination Dual Immune Checkpoint Blockade and Photothermal Therapy
- (2021) Wenrong Zhao et al. Small
- Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter
- (2021) Tord Hompland et al. Cancers
- Elevated M-MDSCs in Circulation Are Indicative of Poor Prognosis in Diffuse Large B-Cell Lymphoma Patients
- (2021) Zhitao Wang et al. Journal of Clinical Medicine
- A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer
- (2021) Xia Yang et al. Aging-US
- Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy
- (2021) Audrey Lequeux et al. ONCOGENE
- CSF1/CSF1R Axis Blockade Limits Mesothelioma and Enhances Efficiency of Anti-PDL1 Immunotherapy
- (2021) Sophia Fotiou Magkouta et al. Cancers
- Hyperbaric Oxygen Therapy Represses the Warburg Effect and Epithelial–Mesenchymal Transition in Hypoxic NSCLC Cells via the HIF-1α/PFKP Axis
- (2021) Linling Zhang et al. Frontiers in Oncology
- Targeting Tim-3 in Cancer With Resistance to PD-1/PD-L1 Blockade
- (2021) Tian Tian et al. Frontiers in Oncology
- Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
- (2021) Jedd D. Wolchok et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects
- (2021) Meggy Suarez-Carmona et al. Journal for ImmunoTherapy of Cancer
- SNHG3 Functions as miRNA Sponge to Promote Breast Cancer Cells Growth Through the Metabolic Reprogramming
- (2020) Yan Li et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- Development and characterization of a novel anti-OX40 antibody for potent immune activation
- (2020) Zhihui Kuang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from Tumors
- (2020) Kirsty Ford et al. CANCER RESEARCH
- Myeloid-derived suppressor cells—new and exciting players in lung cancer
- (2020) Zhenzhen Yang et al. Journal of Hematology & Oncology
- Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma
- (2020) Ann-Lii Cheng et al. JOURNAL OF HEPATOLOGY
- CRISPR-engineered T cells in patients with refractory cancer
- (2020) Edward A. Stadtmauer et al. SCIENCE
- Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy
- (2020) Raefa Abou Khouzam et al. SEMINARS IN CANCER BIOLOGY
- Resistance to Checkpoint Inhibition in Cancer Immunotherapy
- (2020) Luisa Barrueto et al. Translational Oncology
- IL6 Induces an IL22+ CD8+ T-cell Subset with Potent Antitumor Function
- (2020) Michael St. Paul et al. Cancer Immunology Research
- Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
- (2020) Andrew M. K. Law et al. Cells
- Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice
- (2020) Sharmilla Devi Jayasingam et al. Frontiers in Oncology
- Tumor-Derived Retinoic Acid Regulates Intratumoral Monocyte Differentiation to Promote Immune Suppression
- (2020) Samir Devalaraja et al. CELL
- Primary analysis of a randomized, double-blind, phase II study of the anti-TIGIT antibody tiragolumab (tira) plus atezolizumab (atezo) versus placebo plus atezo as first-line (1L) treatment in patients with PD-L1-selected NSCLC (CITYSCAPE).
- (2020) Delvys Rodriguez-Abreu et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study
- (2020) Dmitriy Zamarin et al. JOURNAL OF CLINICAL ONCOLOGY
- Exosomal miRNAs in tumor microenvironment
- (2020) Shiming Tan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy
- (2020) Aaron R Lim et al. eLife
- The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and Their Clinical Implications
- (2020) Devis Pascut et al. Cancers
- Cancer immunotherapy: Current applications and challenges
- (2020) Jin-Yu Sun et al. CANCER LETTERS
- Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials
- (2020) Omid Kooshkaki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma
- (2020) Peng-Fei Zhang et al. Molecular Cancer
- Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
- (2020) Chunxiao Li et al. Molecular Cancer
- The Roles of CD8+ T Cell Subsets in Antitumor Immunity
- (2020) Michael St. Paul et al. TRENDS IN CELL BIOLOGY
- Tim-3 finds its place in the cancer immunotherapy landscape
- (2020) Nandini Acharya et al. Journal for ImmunoTherapy of Cancer
- Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
- (2020) Hans Raskov et al. BRITISH JOURNAL OF CANCER
- T-cell tumour exclusion and immunotherapy resistance: a role for CAF targeting
- (2020) Christopher J. Hanley et al. BRITISH JOURNAL OF CANCER
- TIGIT Can Exert Immunosuppressive Effects on CD8+ T Cells by the CD155/TIGIT Signaling Pathway for Hepatocellular Carcinoma In Vitro
- (2020) Changkun Zhang et al. JOURNAL OF IMMUNOTHERAPY
- Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy
- (2020) Si-Yu Zhang et al. PHARMACOLOGICAL RESEARCH
- The vitamin D analogue calcipotriol promotes an anti-tumorigenic phenotype of human pancreatic CAFs but reduces T cell mediated immunity
- (2020) Laia Gorchs et al. Scientific Reports
- LAG-3: from molecular functions to clinical applications
- (2020) Takumi Maruhashi et al. Journal for ImmunoTherapy of Cancer
- CD25-targeted antibody–drug conjugate depletes regulatory T cells and eliminates established syngeneic tumors via antitumor immunity
- (2020) Francesca Zammarchi et al. Journal for ImmunoTherapy of Cancer
- Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
- (2020) Sreya Bagchi et al. Annual Review of Pathology-Mechanisms of Disease
- Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment
- (2020) Wenxi Zhou et al. BIOMATERIALS
- Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy
- (2020) Sundee Dees et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy
- (2020) Richard Lee Barrett et al. eLife
- DC-Based Vaccines for Cancer Immunotherapy
- (2020) Chunmei Fu et al. Vaccines
- PD-1 Signaling Promotes Tumor-Infiltrating Myeloid-Derived Suppressor Cells and Gastric Tumorigenesis in Mice
- (2020) Woosook Kim et al. GASTROENTEROLOGY
- Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
- (2019) Xianjie Jiang et al. Molecular Cancer
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Tim-3/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients
- (2019) Emeric Limagne et al. OncoImmunology
- Current Status and Future Directions of Immunotherapy in Renal Cell Carcinoma
- (2019) Bryden Considine et al. Current Oncology Reports
- Cancer‐associated fibroblasts promote PD‐L1 expression in mice cancer cells via secreting CXCL5
- (2019) Ziqian Li et al. INTERNATIONAL JOURNAL OF CANCER
- Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion
- (2019) Deepali V. Sawant et al. NATURE IMMUNOLOGY
- PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
- (2019) Takahiro Kamada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting hypoxia-induced carbonic anhydrase IX enhances immune checkpoint blockade locally and systemically
- (2019) Shawn C Chafe et al. Cancer Immunology Research
- The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation
- (2019) Anne Månsson Kvarnhammar et al. Journal for ImmunoTherapy of Cancer
- Review of the Isolation, Characterization, Biological Function, and Multifarious Therapeutic Approaches of Exosomes
- (2019) Sangiliyandi Gurunathan et al. Cells
- The STAT3 inhibitor galiellalactone inhibits the generation of MDSC‐like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors
- (2019) Rebecka Hellsten et al. PROSTATE
- Immune checkpoints in the tumor microenvironment
- (2019) Salman M. Toor et al. SEMINARS IN CANCER BIOLOGY
- LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy
- (2019) Mónica Pascual-García et al. Nature Communications
- Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-κB pathways
- (2019) Mingyu Qian et al. ONCOGENE
- Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma
- (2019) Lei Wu et al. Cancer Immunology Research
- Therapeutic strategies for the costimulatory molecule OX40 in T-cell mediated immunity
- (2019) Yu Fu et al. Acta Pharmaceutica Sinica B
- Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
- (2019) Muhammad Zaeem Noman et al. Cells
- Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort
- (2019) Neal E. Ready et al. Journal of Thoracic Oncology
- Cancer-Derived Succinate Promotes Macrophage Polarization and Cancer Metastasis via Succinate Receptor
- (2019) Jing-Yiing Wu et al. MOLECULAR CELL
- TIGIT as an emerging immune checkpoint
- (2019) H. Harjunpää et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models
- (2019) Sarah Greene et al. CLINICAL CANCER RESEARCH
- Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer
- (2019) Rei Mizuno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Harnessing tumor-associated macrophages as aids for cancer immunotherapy
- (2019) Xiaolei Li et al. Molecular Cancer
- TIGIT immune checkpoint blockade restores CD8+T cell immunity against multiple myeloma
- (2018) Camille Guillerey et al. BLOOD
- Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia
- (2018) Marina Wierz et al. BLOOD
- Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
- (2018) Ana Costa et al. CANCER CELL
- Exosomal lncRNA 91H is associated with poor development in colorectal cancer by modifying HNRNPK expression
- (2018) Tianyi Gao et al. Cancer Cell International
- CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy
- (2018) Ryuma Tokunaga et al. CANCER TREATMENT REVIEWS
- Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth
- (2018) Yi Yang et al. CELL RESEARCH
- Cancer-Associated Fibroblasts Affect Intratumoral CD8+and FoxP3+T Cells via Interleukin 6 in the Tumor Microenvironment
- (2018) Takuya Kato et al. CLINICAL CANCER RESEARCH
- IL-2 and Beyond in Cancer Immunotherapy
- (2018) John M. Wrangle et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment
- (2018) Zhenqiang Sun et al. Molecular Cancer
- T cell–induced CSF1 promotes melanoma resistance to PD1 blockade
- (2018) Natalie J. Neubert et al. Science Translational Medicine
- Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T Cells to protect tumour cells
- (2018) Matthew A. Lakins et al. Nature Communications
- OX40 expression in hepatocellular carcinoma is associated with a distinct immune microenvironment, specific mutation signature, and poor prognosis
- (2018) Kunlin Xie et al. OncoImmunology
- Soluble LAG3 acts as a potential prognostic marker of gastric cancer and its positive correlation with CD8+T cell frequency and secretion of IL-12 and INF-γ in peripheral blood
- (2018) Na Li et al. Cancer Biomarkers
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
- (2018) Jun Wang et al. CELL
- Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity
- (2018) Stéphane Terry et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
- (2018) Priyamvada Jayaprakash et al. JOURNAL OF CLINICAL INVESTIGATION
- Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
- (2018) Danbee Ha et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs
- (2018) Brian J. Christmas et al. Cancer Immunology Research
- The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy
- (2017) Andrew M K Law et al. ENDOCRINE-RELATED CANCER
- Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
- (2017) Frederick Arce Vargas et al. IMMUNITY
- 1,25-dihydroxyvitamin D3 -induced dendritic cells suppress experimental autoimmune encephalomyelitis by increasing proportions of the regulatory lymphocytes and reducing T helper type 1 and type 17 cells
- (2017) Zhongxiang Xie et al. IMMUNOLOGY
- Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review)
- (2017) Rui Dong et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis
- (2017) Elham Safarzadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- COX2/mPGES1/PGE2pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells
- (2017) Victor Prima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation
- (2017) Veronica Huber et al. SEMINARS IN CANCER BIOLOGY
- Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications
- (2017) Zhao-Shan Niu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Increasing Tumor-Infiltrating T Cells through Inhibition of CXCL12 with NOX-A12 Synergizes with PD-1 Blockade
- (2017) Dirk Zboralski et al. Cancer Immunology Research
- TTI-621 (SIRPαFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets
- (2017) Gloria H. Y. Lin et al. PLoS One
- Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs
- (2016) Roger M. Phillips CANCER CHEMOTHERAPY AND PHARMACOLOGY
- FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling
- (2016) Xuguang Yang et al. CANCER RESEARCH
- Lymphocyte-activation gene-3, an important immune checkpoint in cancer
- (2016) Yayi He et al. CANCER SCIENCE
- Fibroblast activation in cancer: when seed fertilizes soil
- (2016) Sanya-Eduarda Kuzet et al. CELL AND TISSUE RESEARCH
- LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
- (2016) Almut Brand et al. Cell Metabolism
- Extracellular Vesicles in Brain Tumor Progression
- (2016) Esterina D’Asti et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab
- (2016) A. Martens et al. CLINICAL CANCER RESEARCH
- TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding
- (2016) Penka S. Petrova et al. CLINICAL CANCER RESEARCH
- Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer
- (2016) Gemma Ferrer-Mayorga et al. GUT
- Exosomes and tumor-mediated immune suppression
- (2016) Theresa L. Whiteside JOURNAL OF CLINICAL INVESTIGATION
- Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
- (2016) Olivier De Henau et al. NATURE
- PI3Kγ is a molecular switch that controls immune suppression
- (2016) Megan M. Kaneda et al. NATURE
- Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
- (2016) Shohei Koyama et al. Nature Communications
- Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation
- (2016) J-t Cheng et al. Oncogenesis
- Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages – a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape
- (2016) Itsaso Montalbán del Barrio et al. Journal for ImmunoTherapy of Cancer
- Expression of the Long Non-Coding RNA HOTAIR Correlates with Disease Progression in Bladder Cancer and Is Contained in Bladder Cancer Patient Urinary Exosomes
- (2016) Claudia Berrondo et al. PLoS One
- Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
- (2015) R. Hughes et al. CANCER RESEARCH
- Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4 + T- Cells, Which Dampen CD8 + T-cell Antitumor Reactivity
- (2015) Marco Donia et al. CANCER RESEARCH
- Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy
- (2015) Shari Pilon-Thomas et al. CANCER RESEARCH
- CSF-1/CSF-1R targeting agents in clinical development for cancer therapy
- (2015) Carola H Ries et al. CURRENT OPINION IN PHARMACOLOGY
- Endogenous prostaglandin E2 potentiates anti-inflammatory phenotype of macrophage through the CREB-C/EBP-β cascade
- (2015) Yi Rang Na et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma
- (2015) Xiaoguang Li et al. GUT
- CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA
- (2015) Alice Conigliaro et al. Molecular Cancer
- Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis
- (2015) Miranda Y. Fong et al. NATURE CELL BIOLOGY
- An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction
- (2015) Chen Zhu et al. Nature Communications
- Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer
- (2015) Chiao-Wen Kang et al. Scientific Reports
- CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function
- (2015) Eunyoung Chun et al. Cell Reports
- Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
- (2015) T. Kouo et al. Cancer Immunology Research
- Dragging Ras Back in the Ring
- (2014) Andrew G. Stephen et al. CANCER CELL
- Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
- (2014) Berna C. Özdemir et al. CANCER CELL
- Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
- (2014) Carola H. Ries et al. CANCER CELL
- LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses
- (2014) F. Xu et al. CANCER RESEARCH
- Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy
- (2014) Mara H. Sherman et al. CELL
- Enhanced suppressor function of TIM-3+FoxP3+regulatory T cells
- (2014) Anne-Sophie Gautron et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Human OX40 tunes the function of regulatory T cells in tumor and nontumor areas of hepatitis C virus-infected liver tissue
- (2014) Silvia Piconese et al. HEPATOLOGY
- Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses
- (2014) Nicole Joller et al. IMMUNITY
- All trans-retinoic acid abrogates the pro-tumorigenic phenotype of prostate cancer tumor-associated macrophages
- (2014) Panagiotis Tsagozis et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer
- (2014) M. C. B. Tan et al. JOURNAL OF IMMUNOLOGY
- CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
- (2014) Yu-Hwa Huang et al. NATURE
- Drugging the undruggable RAS: Mission Possible?
- (2014) Adrienne D. Cox et al. NATURE REVIEWS DRUG DISCOVERY
- Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance
- (2014) Nan Wang et al. Frontiers in Immunology
- CXCR2-Expressing Myeloid-Derived Suppressor Cells Are Essential to Promote Colitis-Associated Tumorigenesis
- (2013) Hiroshi Katoh et al. CANCER CELL
- Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer
- (2013) Xiongyan Wu et al. CANCER LETTERS
- Inhibition of CSF-1 Receptor Improves the Antitumor Efficacy of Adoptive Cell Transfer Immunotherapy
- (2013) S. Mok et al. CANCER RESEARCH
- Targeting the HIF pathway in inflammation and immunity
- (2013) Carsten C Scholz et al. CURRENT OPINION IN PHARMACOLOGY
- Antibodies Targeting Human OX40 Expand Effector T Cells and Block Inducible and Natural Regulatory T Cell Function
- (2013) K. S. Voo et al. JOURNAL OF IMMUNOLOGY
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans
- (2013) D. Sugiyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I
- (2013) Peter Ellinghaus et al. Cancer Medicine
- Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia
- (2013) Christopher P. Guise et al. Chinese Journal of Cancer
- C-C motif chemokine CCL3 and canonical neutrophil attractants promote neutrophil extravasation through common and distinct mechanisms
- (2012) C. A. Reichel et al. BLOOD
- Demand-adapted regulation of early hematopoiesis in infection and inflammation
- (2012) H. Takizawa et al. BLOOD
- EO9 (Apaziquone): from the clinic to the laboratory and back again
- (2012) Roger M Phillips et al. BRITISH JOURNAL OF PHARMACOLOGY
- CXCR3+ T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity
- (2012) N. Redjimi et al. CANCER RESEARCH
- Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes
- (2012) A. Calcinotto et al. CANCER RESEARCH
- Circulatory Antigen Processing by Mucosal Dendritic Cells Controls CD8+ T Cell Activation
- (2012) Sun-Young Chang et al. IMMUNITY
- The TIGIT/CD226 Axis Regulates Human T Cell Function
- (2012) E. Lozano et al. JOURNAL OF IMMUNOLOGY
- Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells Mediate CCR5-Dependent Recruitment of Regulatory T Cells Favoring Tumor Growth
- (2012) E. Schlecker et al. JOURNAL OF IMMUNOLOGY
- TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression
- (2012) Xin Gao et al. PLoS One
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
- (2012) Gregg L. Semenza TRENDS IN PHARMACOLOGICAL SCIENCES
- The development and immunosuppressive functions of CD4+ CD25+ FoxP3+ regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway
- (2012) Akio Ohta et al. Frontiers in Immunology
- PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
- (2011) N. Obermajer et al. CANCER RESEARCH
- Tumor-Associated Macrophages Promote Angiogenesis and Melanoma Growth via Adrenomedullin in a Paracrine and Autocrine Manner
- (2011) P. Chen et al. CLINICAL CANCER RESEARCH
- MHC Class II Engagement by Its Ligand LAG-3 (CD223) Contributes to Melanoma Resistance to Apoptosis
- (2011) P. Hemon et al. JOURNAL OF IMMUNOLOGY
- Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302
- (2011) F. Meng et al. MOLECULAR CANCER THERAPEUTICS
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
- (2011) Bin-Zhi Qian et al. NATURE
- Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma
- (2011) Young-Ah Cho et al. ORAL ONCOLOGY
- Dendritic Cell-Derived Exosomes for Cancer Immunotherapy: What's Next?
- (2010) S. Viaud et al. CANCER RESEARCH
- IL-6: Regulator of Treg/Th17 balance
- (2010) Akihiro Kimura et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interleukin-2 and Inflammation Induce Distinct Transcriptional Programs that Promote the Differentiation of Effector Cytolytic T Cells
- (2010) Matthew E. Pipkin et al. IMMUNITY
- LAG-3 Expression Defines a Subset of CD4+CD25highFoxp3+ Regulatory T Cells That Are Expanded at Tumor Sites
- (2010) C. Camisaschi et al. JOURNAL OF IMMUNOLOGY
- Tumor-Activated Monocytes Promote Expansion of IL-17-Producing CD8+ T Cells in Hepatocellular Carcinoma Patients
- (2010) D.-M. Kuang et al. JOURNAL OF IMMUNOLOGY
- Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy
- (2010) Pravin Mishra et al. JOURNAL OF LEUKOCYTE BIOLOGY
- IL-35-mediated induction of a potent regulatory T cell population
- (2010) Lauren W Collison et al. NATURE IMMUNOLOGY
- Autocrine TGF- and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts
- (2010) Y. Kojima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sunitinib Inhibition of Stat3 Induces Renal Cell Carcinoma Tumor Cell Apoptosis and Reduces Immunosuppressive Cells
- (2009) H. Xin et al. CANCER RESEARCH
- PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV
- (2009) Debora Franceschini et al. JOURNAL OF CLINICAL INVESTIGATION
- The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation
- (2009) Meghan A Koch et al. NATURE IMMUNOLOGY
- Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production
- (2009) H. Fujita et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
- (2008) Li Yang et al. CANCER CELL
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
- (2008) Johan Skog et al. NATURE CELL BIOLOGY
- The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
- (2008) Xin Yu et al. NATURE IMMUNOLOGY
- CTLA-4 Control over Foxp3+ Regulatory T Cell Function
- (2008) K. Wing et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started